25,116 Shares in CME Group Inc. (NASDAQ:CME) Bought by Burling Wealth Partners LLC

Burling Wealth Partners LLC bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 25,116 shares of the financial services provider's stock, valued at approximately $5,833,000. CME Group comprises 1.2% of Burling Wealth Partners LLC's holdings, making the stock its 24th largest holding.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. Syon Capital LLC lifted its stake in CME Group by 41.5% in the fourth quarter. Syon Capital LLC now owns 3,255 shares of the financial services provider's stock valued at $756,000 after purchasing an additional 954 shares during the last quarter. MGO One Seven LLC lifted its stake in CME Group by 16.9% in the fourth quarter. MGO One Seven LLC now owns 6,881 shares of the financial services provider's stock valued at $1,598,000 after purchasing an additional 994 shares during the last quarter. Pinebridge Investments L.P. lifted its stake in CME Group by 22.5% in the fourth quarter. Pinebridge Investments L.P. now owns 193,973 shares of the financial services provider's stock valued at $45,046,000 after purchasing an additional 35,572 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Finally, Alta Advisers Ltd lifted its stake in CME Group by 17.6% in the fourth quarter. Alta Advisers Ltd now owns 1,176 shares of the financial services provider's stock valued at $273,000 after purchasing an additional 176 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Price Performance

NASDAQ:CME traded up $1.77 during mid-day trading on Tuesday, reaching $269.69. The stock had a trading volume of 386,675 shares, compared to its average volume of 2,149,168. The firm has a 50 day moving average price of $259.12 and a two-hundred day moving average price of $242.41. The stock has a market capitalization of $97.18 billion, a P/E ratio of 27.87, a P/E/G ratio of 6.76 and a beta of 0.43. CME Group Inc. has a one year low of $190.70 and a one year high of $273.42. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 EPS. CME Group's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were given a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.85%. This is an increase from CME Group's previous quarterly dividend of $1.15. CME Group's payout ratio is presently 50.30%.

Insider Buying and Selling at CME Group

In other news, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares of the company's stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 29,076 shares of company stock worth $7,399,696. 0.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CME shares. Bank of America raised their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. reduced their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Barclays lifted their target price on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Piper Sandler lifted their target price on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, Erste Group Bank raised CME Group to a "strong-buy" rating in a report on Monday, March 17th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus price target of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.